- Home
- ATHA vs HWH Comparison
ATHA vs HWH Comparison
Compare ATHA & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- HWH
- Stock Information
- Founded
- ATHA 2011
- HWH 2021
- Country
- ATHA United States
- HWH United States
- Employees
- ATHA N/A
- HWH N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- HWH Other Pharmaceuticals
- Sector
- ATHA Health Care
- HWH Health Care
- Exchange
- ATHA Nasdaq
- HWH Nasdaq
- Market Cap
- ATHA 22.3M
- HWH 21.2M
- IPO Year
- ATHA 2020
- HWH N/A
- Fundamental
- Price
- ATHA $0.54
- HWH $0.50
- Analyst Decision
- ATHA Buy
- HWH
- Analyst Count
- ATHA 4
- HWH 0
- Target Price
- ATHA $11.25
- HWH N/A
- AVG Volume (30 Days)
- ATHA 325.4K
- HWH 2.3M
- Earning Date
- ATHA 11-07-2024
- HWH 12-27-2024
- Dividend Yield
- ATHA N/A
- HWH N/A
- EPS Growth
- ATHA N/A
- HWH N/A
- EPS
- ATHA N/A
- HWH N/A
- Revenue
- ATHA N/A
- HWH $1,174,367.00
- Revenue This Year
- ATHA N/A
- HWH N/A
- Revenue Next Year
- ATHA N/A
- HWH N/A
- P/E Ratio
- ATHA N/A
- HWH N/A
- Revenue Growth
- ATHA N/A
- HWH 44.55
- 52 Week Low
- ATHA $0.41
- HWH $0.41
- 52 Week High
- ATHA $4.30
- HWH $10.65
- Technical
- Relative Strength Index (RSI)
- ATHA 36.91
- HWH 38.56
- Support Level
- ATHA $0.56
- HWH $0.55
- Resistance Level
- ATHA $0.61
- HWH $0.72
- Average True Range (ATR)
- ATHA 0.04
- HWH 0.16
- MACD
- ATHA -0.01
- HWH -0.04
- Stochastic Oscillator
- ATHA 8.45
- HWH 0.01
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About HWH HWH International Inc.
HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.